Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium
Ibrahim, A., Aboutaleb, A., Ahmad, M., A.Abdel-Aleem, J. (2023). Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium. EKB Journal Management System, 5(1), 33-46. doi: 10.21608/sjpms.2023.206904.1019
Ahmed Sayed Ibrahim; Ahmed El-Sayed Aboutaleb; Mahrous Osman Ahmad; Jelan Abdel_razik A.Abdel-Aleem. "Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium". EKB Journal Management System, 5, 1, 2023, 33-46. doi: 10.21608/sjpms.2023.206904.1019
Ibrahim, A., Aboutaleb, A., Ahmad, M., A.Abdel-Aleem, J. (2023). 'Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium', EKB Journal Management System, 5(1), pp. 33-46. doi: 10.21608/sjpms.2023.206904.1019
Ibrahim, A., Aboutaleb, A., Ahmad, M., A.Abdel-Aleem, J. Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium. EKB Journal Management System, 2023; 5(1): 33-46. doi: 10.21608/sjpms.2023.206904.1019

Silver Nanoparticles Coated with Polymers: Synthesis, Characterization and Loading with Rousvastatin Calcium

Sphinx Journal of Pharmaceutical and Medical Sciences
Article 2, Volume 5, Issue 1, May 2023, Page 33-46  XML PDF (934.93 K)
Document Type: Original research articles
DOI: 10.21608/sjpms.2023.206904.1019
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Sayed Ibrahim email 1; Ahmed El-Sayed Aboutaleb2; Mahrous Osman Ahmad2; Jelan Abdel_razik A.Abdel-Aleem2
1Department of pharmaceutics, faculty of pharmacy, Sphinx University, Assiut,Egypt
2Department of Industrial pharmacy, Faculty of pharmacy, Assiut University, Assiut, Egypt
Abstract
This work was conducted with the aim of formulating the antihyperlipidemic statin; rousvastatin calcium (RVC) using silver nanoparticles (AgNPs) as a carrier. This delivery system was designed to make use of the nanoscale-enormous surface area of AgNPs in enhancing the anti-inflammatory characteristics of both the drug and the carrier. The probability of the occurrence of interaction between RVC and the excipients used in synthesizing AgNPs was investigated using differential scanning calorimetry (DSC) and Fourier transfer infrared spectroscopy (FT-IR)). Silver nanoparticles (AgNPs) were synthesized using different capping agents; PEG 6000, sodium alginate, polyvinyl alcohol (PVA) , β-cyclodextrin (β-CD), hydroxylpropyl-β-cyclodextrin (HPβ-CD) and Polyvinylpyrrolidone K90 (PVPK90). The silver nitrate was reduced using sodium borohydride. The formed AgNPs were then characterized by measuring their size and zeta potential and scanning electron microscopy (SEM). The results of DSC and Ft-IR revealed the absence of interaction between the used excipients and RVC. The loading capacity of AgNPs toward RVC was found to be dependent on the capping agent. The characterization of AgNPs by zeta analyzer shown the particle size diameter ranged from 184.7 to 812.1 nm depending on the capping agent. The values of zeta potential ranged from -32.8 to -10.5 Mv.
Keywords
Silver nanoparticles; rousvastatin calcium; drug-excipient compatibility; chemical synthesis of silver nanoparticles; nanoparticles characterization; encapsulating efficiency
Statistics
Article View: 96
PDF Download: 82